1960)) from AzUR, decreased activity of one or both enzymes might be associated with resistance to AzU. Handschumacher et al. (1962) stated that in resistant bacteria and certain strains of experimental tumours (unidentified) a common feature was the lack of formation of the 5'-phosphate from AzUR. Thus, decreased phosphorylation of uridine and AzUR to the respective nucleotides was associated with the development of resistance to AzUR in L-5178-Y leukaemia cells (Pasternak et al., 1961) . However, a mutant of Streptococcus faecalis resistant to AzU was unable to convert AzU or uracil to the respective nucleoside, but could phosphorylate uridine (Handschumacher, 1957) . In comparison, development of resistance to AzUR during therapy of human neoplastic disease has been associated with an adaptive increase in the synthesis of pyrimidines via the de novo pathway Handschumacher et al., 1962) .
During our experiments, it soon became apparent that there were large variations in the specific activities of uridine kinase and uridine phosphorylase of the untreated EAC cells, as well as of the AzU-and AzUR-treated sublines, in successive transplant generations. No trends toward decreased or increased activity were discernible. This communication reports the variations in the specific activities of these enzymes which were observed in fresh cell-free extracts of the cells during several transplant generations. Although decreased sensitivity to AzU and AzUR could be demonstrated in the EAC sublines treated with AzU and AzUR, respectively, no significant changes were observed in the specific activities of the enzymes.
MATERIALS AND METHODS

Chemicals
Uridine-2-'4C (specific activity of 16 1 ,tCi/,mole; radio-chemically pure) was obtained from New England Nuclear Corp., Boston, Mass. Uridine (A grade), uridine 5'-monophosphate (UMP) (disodium salt; A grade) and 6-azauridine (A grade; chromatographically homogeneous) were purchased from Calbiochem, Los Angeles, California. Adenine, uracil, 6-azauracil (1 ,2,4-triazine-3,5-dione) and the barium salt of D-3-phosphoglyceric acid were obtained from Nutritional Biochemicals Corp., Cleveland, Ohio. A solution of the potassium salt of D-3-phosphoglyceric acid was prepared by adding an equivalent amount of K2S04 to an acidic solution of the barium salt to precipitate barium ions as BaSO4.
The supernatant solution obtained upon centrifugation was neutralized with KOH.
Adenosine 5'-triphosphate (ATP) (disodium salt) was purchased from Sigma Chemical Co., St. Louis, Mo., and bovine serum albumin (fraction V) was obtained from The Armour Laboratories, Kankakee, Illinois. 5-Fluorouracil was a gift from Hoffmann-La Roche Limited, Montreal, P.Q.
For injection into mice, azauracil and azauridine were dissolved in sterile 0.9% NaCl to form concentrations of 10 mg. per ml. Azauracil was dissolved, just before use, by heating the suspension in hot water for several minutes.
Fluorouracil was dissolved in sterile 0.9% NaCl at a concentration of 10 mg.
per ml.
Mice
Male Swiss strain mice (Connaught), weighing between 18 and 26 g. each, were obtained from the Animal Annex, University of Saskatchewan, Saskatoon, or from the Connaught Medical Research Laboratories, University of Toronto, Toronto, Ontario. The mice were housed in groups of 5 or 6 per cage, and were fed mouse and rat pellets and water ad libitum.
Tumour
The parental (sensitive) Ehrlich ascites carcinoma (EAC/s) which was used was a hypotetraploid line having a modal chromosome number of 74 The protein content of the cell-free extract was determined by the method of Lowry et al. (1951) with the use of bovine serum albumin (fraction V) as a standard. The haemoglobin content was estimated by the cyanomethaemoglobin method of Evelyn and Malloy (1938) and was subtracted from the total protein content for the purpose of calculating enzyme specific activities. Cells from grossly bloody ascites tumours were not used.
Assay of enzyme activities
Uridine kinase and uridine phosphorylase activities of the cell-free extracts of the tumour cells were estimated simultaneously by a radioisotopic method similar to that employed by Skold (1960d) for the measurement of these activities in acetone powder extracts of EAC cells.
The enzyme reaction medium (0.3 ml.) contained MgCl2 (40 mM); tris(hydroxymethyl)aminomethane (Tris) buffer, pH 7-4 (33 mm); phosphate buffer, pH 7.4 (25.5 mM); ATP (13.3 mM); potassium D-3-phosphoglycerate (24.7 mM); uridine-2-14C (26.7 mair, 0 032 ,uCi) and the cell extract. Incubations were carried out at 37-38°C. for 15 minutes, and enzymatic activity was terminated by the addition of 0 03 ml. of ice-cold 4 M perchloric acid. The supernatant solution, obtained by centrifugation, was heated in boiling water for 1 hour to break pyrophosphate and purine-glycosyl bonds. Perchlorate ions were precipitated from the cooled solution as KC104, by neutralization with cold 4 M KOH, and sedimented by centrifugation.
A 0 05 ml. aliquot of the supernatant solution, obtained by centrifugation, was applied to a strip of Whatman No. 1 filter paper (2 cm. or 1 inch wide) and subjected to descending chromatography in absolute ethanol-saturated Na2B407 gas-flow system as described by Blair and Hall (1965) . The percentages of total radioactivity in uracil, uridine and UMP were calculated for each sample, and the amounts of uracil and UMP formed from uridine-2-14C were calculated from these values and the specific activity of uridine-2-14C.
Because the enzymatic formation of uracil and UMP is not perfectly linear with enzyme concentration (Skold, 1960d) , the assay for each cell extract was done with several enzyme concentrations to ensure the rectilinear portion of the activity curve. Fig. 1 shows the formation of uracil and UMP (15 minutes) amount of EAC/s cell extract in a representative experiment. Enzyme activities were calculated from the initial slopes of the activity curves ( Fig. 1) as ,umoles of uracil or UMP formed per mg. of protein (corrected for haemoglobin) per hour. Fig. 2 shows that the formation of UMP was linear with time for 15 minutes, under the conditions described above, while uracil formation was linear for about 30 minutes.
The concentrations of MgCl2 and potassium 3-phosphoglycerate which were used in the enzyme reaction medium were identical to those employed by Skold (1960d), whereas the concentrations of ATP, Tris, phosphate and uridine-2-14C were, respectively, 1-65, 1'15, 1P55 and 15-3 times as large as those used by Skold (1960d) . Fig. 3 and 4 show that the concentrations of phosphate and uridine, respectively, which were used in the present experiments were optimal. Adenosine 5'-triphosphate was retained throughout the enzymatic reaction, and its concentration, measured by a combined spectrophotometric and anion-exchange (Blair, Stone and Potter, 1960) , at the end (15 minutes; 0-06 ml. of EAC/s cell extract) was 7 18 mm. When the initial ATP concentration was 8-0 mm rather than 13-3 mM, UMP formation was 98%, and uracil formation 124%, of the formation at the higher concentration. The specific activities of uridine kinase and uridine phosphorylase in extracts of EAC/s cells varied appreciably, and apparently randomly, over the span of 35 cell transplant generations studied (Fig. 5) Cells of transplant generations 12-14 were obtained from 10-day-old tumours, whereas cells of generations 16, 24, 33, 36 and 46 came from 8-day-old tumours, and cells of the other generations were from 9-day-old tumours. Close examination of Fig. 5 shows that there is no obvious correlation between the activities and the age of the tumour: The highest and lowest activities of uridine phosphorylase were obtained for extracts from 8-day-old tumours, and, although the highest uridine kinase activity was obtained for an extract of cells from an 8-day-old tumour, the third-lowest activity was also obtained for cells from a tumour of the same age. However, the average mean specific activities (,umoles/hr/mg. protein ± standard deviation) of uridine kinase for 8, 9 and 10-day-old tumour cells were 1-932 ± 0-554, 19481 ± 0-416 and 19632 ± 0-536, respectively , and the corresponding average mean specific activities for uridine phosphorylase were 0-946 + 0-334, 0-831 ± 0*233 and 0-715 ± 0-157, respectively. There was no significant difference between the three values in each group. Growth of the EAC/s tumour in male Swiss mice was similar to that described by Klein and Revesz (1953) for the Ehrlich ascites carcinoma, with no definite exponential phase, and the terminal phase began at about 9 days after cell inoculation (6.2 x 106 cells) (Rainnie, 1967; Rainnie and Blair, 1969) . The viability of free cells, collected from the peritoneal cavities of 10 tumour-bearing mice each day during the determination of the growth curve, was estimated by a dye-exclusion method (Phillips and Terryberry, 1957) with erythrosin B. The viability of cells ranged from 71-8 to 92.7% during the entire growth period, and was 83 1, 87-1 and 89.4% for cells from 8-, 9-and 10-day-old tumours, respectively (Rainnie, 1967) . Cell-size distribution studies (Coulter cell counter and plotter) on the same cell populations did not indicate any change in the constituent populations between days 3 and 12 of tumour growth (Rainnie, 1967; Rainnie and Blair, 1969) . The specific activities of uridine kinase and uridine phosphorylase in extracts of EAC/AzU1 and EAC/AzU2 cells from 8-or 9-day-old tumours also varied considerably over the 33 and 17 cell transplant generations, respectively, which were investigated (Fig. 6) . No trend could be observed toward decreased or increased uridine phosphorylase specific activities with 6-azauracil treatment. The mean protein at transplant generation No. 17 to 1-125 ,umoles/hr/mg. protein at generation No. 12. Remarkable similarity is seen in the specific activities, and in the variation, from transplant generation to transplant generation, in the activities of the enzyme from the two cell sublines. This result suggests (a) that cells of the two sublines are biochemically similar and (b) that the enzymes from both types of cells react similarly to factors involved in assaying the enzyme activity.
The specific activity of uridine kinase from EAC/AzUj cells appeared first of all to increase, and, later, to decrease with AzU treatment. A similar rise was observed for the EAC/AzU2 subline, but this subline was discontinued before any subsequent decrease was observed. 
Specific activities of uridine kinase and uridine phosphorylase in extracts of EAC/AzUUR cells
The specific activities of the two " uracil pathway " enzymes in extracts of EAC/AzUR cells also varied considerably over 11 cell transplant generations from the commencement of treatment with 6-azauridine, without any definite trend toward increased or decreased activities (Fig. 7) . In this case the enzyme specific activities were determined at each successive transplant generation, where possible, in order to ascertain the changes from one generation to the next.
The EAC/AzU2 (Table II) Tables  I and II) were not very sensitive to an AzU dose of 250 mg./kg./day (Table I) but were sensitive to a doubled dose (Table II) . The effect of changing the dose of AzU from 250 to 750 mg./kg./day for EAC/AzU, cells at transplant generation No. 4 was an increase in the therapeutic index which later decreased to zero at generation No. 13. Decreased sensitivity of EAC/AzUR cells to 6-azauridine was apparent after 12 cell transplant generations under treatment with 150 mg. of AzUR/kg./day for three generations and with 300 mg. of AzUR/kg./day for nine generations (Table  III) . Change of the dosage from 150 to 300 mg./kg./day produced an appreciable increase in the therapeutic index which decreased in succeeding generations.
In Table IV 14*7±1-25 * T, treated; C, control. Treated animals received 500 mg. 6-azauracil/kg./day for 6 days.
tT.I., therapeutic index. No. of mice T* C* 6 6 6 6 6 6 6 6 6 6 6 6 6 6
Mean survival time in days + S.D. Table V presents the mean total packed cell volume data for the experiments with 6-azauracil and 6-azauridine presented in Table IV , and for some additional experiments with EAC/s cells with 6-azauracil and 6-azauridine. It is readily apparent that corresponding doses of AzU or AzUR inhibited the growth of EAC/s cells more effectively than that of EAC/AzU1 cells. Thus, these data support the survival data in showing that the EAC/AzU1 cells are less sensitive to AzU and AzUR than are EAC/s cells. Comparison of the enzyme specific activities (Fig. 6 ) of the EAC/AzU1 subline with the azauracil-sensitivity data (Tables I, IV and V) shows that there was no correlation between uridine kinase and uridine phosphorylase activity of the cell extracts and sensitivity to azauracil. Similarly, there was no apparent correlation between the enzyme specific activities of the EAC/AzU2 cells (Fig. 6 ) and sensitivity to azauracil (Table II) , or between the enzyme specific activities of the EAC/AzUR cells (Fig. 7) and sensitivity to azauridine (Table III) .
DISCUSSION
In the experiments described in this report, alterations in the specific activities of uridine kinase or of uridine phosphorylase, which are activating enzymes for azauracil (Pontis, Degerstedt and Reichard, 1961; Skold, 1960c) , could not be correlated with the development of resistance to 6-azauracil and 6-azauridine in AzU-and AzUR-treated sublines of the Ehrlich ascites carcinoma. This result is similar to that obtained by Reichard et al. (1962) in regard to the development of resistance of Ehrlich ascites carcinoma cells to 5-fluorouracil. In that case two tumour lines became resistant to FU before a decrease in either uridine kinase or uridine phosphorylase occurred, and it appeared that other factors were responsible for the development of the resistant state.
One mechanism of resistance to 6-azauridine, which has been definitely established for L-5178-Y cells cultured in vitro, is decreased uridine kinase activity (Pasternak et al., 1961 , appears to be operative. The work of Pinsky and Krooth (1967a, 1967b) It was pointed out in the " Results " section that the mean activities of either uridine kinase or uridine phosphorylase in extracts from 8-, 9-or 10-day-old tumours were not significantly different with respect to tumour age. Recent experiments (Rainnie and Blair, 1969) , in which the specific activities of the two enzymes were measured in separate assays concurrently with the progression of growth of the Ehrlich ascites carcinoma from an inoculum of 5-2 x 106 cells, indicated that the specific activity of uridine phosphorylase was significantly greater in extracts of cells from 10-day-old tumours than in extracts of cells from 8-or 9-day-old tumours. The results reported in this communication differ from those cited above (Rainnie and Blair, 1969) , but a direct comparison of the two sets of data is not valid because of (1) the different assay methods and (2) the use of cells from different cell transplant generations, which may have been initiated with different cell doses, thus perhaps shifting the growth curve, in the one case, and of cells from only one cell transplant generation in the other. Reichard et al. (1962) considered the irregular variations which they observed in the activities of uridine phosphorylase, uridine kinase and deoxyuridine phosphorylase in acetone powders from four FU-resistant EAC cell lines to be random and probably caused by the inhomogeneity of the animals which were used. Physiological variation was undoubtedly a factor in those experiments, as well as in those described in this report. Numerous other factors must be involved, however, and it is not possible at this time to state what portion of the total effect is contributed by physiological variation. It is apparent that the use of freshly prepared cell extracts or of acetone powders provides essentially the same degree of variation in enzyme specific activities.
Demonstration of resistance to drug therapy is difficult when the drug is not highly effective against the disease state, as in the case of treatment of the Ehrlich ascites carcinoma with 6-azauracil or 6-azauridine. Simultaneous metabolic changes may be small in such cases, and demonstration of them is more difficult when the range of " normal " values is relatively large, as for uridine kinase and uridine phosphorylase in EAC cells. Small, but nevertheless important, alterations may be completely obscured.
SUMMARY
The specific activities of uridine phosphorylase and uridine kinase were determined in freshly prepared cell-free extracts of Ehrlich ascites carcinoma cells and of cells from two 6-azauracil-treated sublines and from one 6-azauridine-treated subline over several cell transplant generations for each cell line. All the drugtreated sublines had become less sensitive (more resistant) to the drug with which they were treated after 12 transplant generations under treatment. However, no definite trend toward decreased or increased activities of uridine kinase or uridine phosphorylase could be correlated with the development of resistance. It was found that the specific activities of the two enzymes in all cell lines varied greatly in successive cell transplant generations. This variation may have obscured any changes in the enzyme activities which may have accompanied the development of resistance to 6-azauracil and 6-azauridine. Cells resistant to 6-azauracil were cross-resistant to 6-azauridine but not to 5-fluorouracil.
